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Biliary atresia (BA) is a rare disease of the infant with unknown pathogenesis. It is characterized by inflammatory, 
progressive destruction of the biliary system leading to liver fibrosis and progressive deterioration of liver function. 
Interleukin-17a (IL-17) has been identified as a cytokine driving inflammatory and autoimmune processes. We 
investigated the role of IL-17 and IL-17 producing cell populations in the pathogenesis of experimental and human 
BA. 
In the rotavirus induced BA mouse model, symptomatic animals had a significantly increased hepatic transcription 
of IL-17. We identified gamma delta (γδ) T cells as the exclusive source of IL-17, while classical Th17 cells were 
completely absent. The increased number of IL-17
+
 γδ T cells in BA+ animals was associated with an up-regulation 
of typical markers of the IL-17-axis, such as IL17a, IL17f, RORγt, CCR6 and the IL-23-receptor. In vivo, blockage 
of IL-17 by administration of monoclonal antibodies ameliorated the clinical course of disease, improved survival 
and serum bilirubin, and reduced liver inflammation. 
In human infants with BA, hepatic transcription of IL-17 was significantly up-regulated compared to patients with 
other neonatal cholestatic diseases, while no differences in IL-17 levels were detected in patient sera. 
Taken together, IL-17 released by lymphocytes bearing the γδ T cell receptor appear to be a causative factor in the 
inflammatory destruction of the biliary system in experimental BA. Furthermore, our data suggest an important 
role of the IL-17 axis in human BA. Thus, targeting the IL-17 axis could be a promising approach for therapeutic 
interventions. 
